| ∧ ∨ Type | ∧ ∨ Title | Principal Investigators | Status | ∧ ∨ Year |
|---|---|---|---|---|
| ASS_NAZ - Bandi da Associazioni e altri Finanziatori privati nazionali |
Targeting the lymphatics as a new strategy in cancer immunotherapy
|
|
Closed | 2010 |
| ASS_NAZ - Bandi da Associazioni e altri Finanziatori privati nazionali |
All-optical fingerprinting of metastatic potential (2° anno)
|
|
Closed | 2020 |
| ASS_NAZ - Bandi da Associazioni e altri Finanziatori privati nazionali |
Targeting allo-reactive Natural Killer cell immune reconstitution in hematologic tumors after bone marrow transplant (2º anno)
|
|
Closed | 2020 |
| ASS_NAZ - Bandi da Associazioni e altri Finanziatori privati nazionali |
Characterization of the Therapeutic Potential of Neurosteroids for CDKL5-Disorder
|
|
Closed | 2019 |
| ASS_NAZ - Bandi da Associazioni e altri Finanziatori privati nazionali |
Association of sphingolipid cell profiles with melanoma progression and prognosis
|
|
Closed | 2015 |
| ASS_NAZ - Bandi da Associazioni e altri Finanziatori privati nazionali |
Unraveling the molecular mechanism of mutated PCDH19 function in Epilepsy with Mental Retardation limited to Females (EFMR)
|
|
Closed | 2014 |
| ASS_NAZ - Bandi da Associazioni e altri Finanziatori privati nazionali |
Study of chordoma tumorigenesis addressing prognostic markers and pharmacological targets
|
|
Closed | 2013 |
| ASS_NAZ - Bandi da Associazioni e altri Finanziatori privati nazionali |
MIRNA as markers of liver transformation and tumor progression in human and experimental models
|
|
Closed | 2012 |
| ASS_NAZ - Bandi da Associazioni e altri Finanziatori privati nazionali |
Association of sphingoluipid cell profiles with melanoma progression and prognosis
|
|
Closed | 2013 |
| ASS_NAZ - Bandi da Associazioni e altri Finanziatori privati nazionali |
Cell therapy with TRIL-armed, genetically engineered or phenotypically redirected, effectors
|
|
Closed | 2010 |
